COVID-19 convalescent plasma and clinical trials: understanding conflicting outcomes

D Focosi, M Franchini, L Pirofski… - Clinical microbiology …, 2022 - Am Soc Microbiol
Convalescent plasma (CP) recurs as a frontline treatment in epidemics because it is
available as soon as there are survivors. The COVID-19 pandemic represented the first …
被引用次数：79 相关文章

COVID-19 Convalescent Plasma and Clinical Trials: Understanding Conflicting Outcomes

D Focosi, M Franchini, LA Pirofski… - Clinical Microbiology …, 2022 - hub.tmu.edu.tw
摘要Convalescent plasma (CP) recurs as a frontline treatment in epidemics because it is
available as soon as there are survivors. The COVID-19 pandemic represented the first …

COVID-19 Convalescent Plasma and Clinical Trials: Understanding Conflicting Outcomes

D Focosi, M Franchini, LA Pirofski… - Clinical …, 2022 - einstein.elsevierpure.com
Convalescent plasma (CP) recurs as a frontline treatment in epidemics because it is
available as soon as there are survivors. The COVID-19 pandemic represented the first …

COVID-19 Convalescent Plasma and Clinical Trials: Understanding Conflicting Outcomes.

D Focosi, M Franchini, LA Pirofski… - Clinical Microbiology …, 2022 - europepmc.org
Convalescent plasma (CP) recurs as a frontline treatment in epidemics because it is
available as soon as there are survivors. The COVID-19 pandemic represented the first …
[HTML] nih.gov

[HTML][HTML] COVID-19 Convalescent Plasma and Clinical Trials: Understanding Conflicting Outcomes

D Focosi, M Franchini, L Pirofski, T Burnouf… - Clinical Microbiology …, 2022 - ncbi.nlm.nih.gov
Convalescent plasma (CP) recurs as a frontline treatment in epidemics because it is
available as soon as there are survivors. The COVID-19 pandemic represented the first …

COVID-19 Convalescent Plasma and Clinical Trials: Understanding Conflicting Outcomes

D Focosi, M Franchini, LA Pirofski… - Clinical …, 2022 - mayoclinic.elsevierpure.com
Convalescent plasma (CP) recurs as a frontline treatment in epidemics because it is
available as soon as there are survivors. The COVID-19 pandemic represented the first …

COVID-19 convalescent plasma and clinical trials: understanding conflicting outcomes.

D Focosi, M Franchini, LA Pirofski, T Burnouf, N Paneth… - 2022 - cabidigitallibrary.org
Convalescent plasma (CP) recurs as a frontline treatment in epidemics because it is
available as soon as there are survivors. The COVID-19 pandemic represented the first …

COVID-19 Convalescent Plasma and Clinical Trials: Understanding Conflicting Outcomes

D Focosi, M Franchini, LA Pirofski… - Clinical …, 2022 - pure.johnshopkins.edu
Convalescent plasma (CP) recurs as a frontline treatment in epidemics because it is
available as soon as there are survivors. The COVID-19 pandemic represented the first …

COVID-19 Convalescent Plasma and Clinical Trials: Understanding Conflicting Outcomes

D Focosi, M Franchini, LA Pirofski… - Clinical …, 2022 - pubmed.ncbi.nlm.nih.gov
Convalescent plasma (CP) recurs as a frontline treatment in epidemics because it is
available as soon as there are survivors. The COVID-19 pandemic represented the first …

COVID-19 Convalescent Plasma and Clinical Trials: Understanding Conflicting Outcomes

D Focosi, M Franchini, LA Pirofski… - Clinical …, 2022 - pubmed.ncbi.nlm.nih.gov
Convalescent plasma (CP) recurs as a frontline treatment in epidemics because it is
available as soon as there are survivors. The COVID-19 pandemic represented the first …